PREVIEW

Left to Right: Gregory D. Koblentz, PH.D., Associate Professor and Director, Biodefense Graduate Program, George Mason University, Robert F. Garry, PH.D., Professor and Associate Dean School of Medicine, Tulane University, Steven C. Quay, M.D., PH.D., Chief Executive Officer Atossa Therapeutics, Inc. and Former Faculty, Stanford University School of Medicine and Richard H. Ebright, PH.D., Board of Governors Professor of Chemistry and Chemical Biology and Laboratory Director, Waksman Institute of Microbiology, Rutgers University are sworn-in during a Senate Committee on Homeland Security and Governmental Affairs hearing to examine origins of COVID-19, focusing on available evidence in the Dirksen Senate Office Building.